Home

Myrrh Commiphora myrrha - Commiphora molmol


1. 6/13/02 Myrrh - Healthwell Notes Commiphora molmol Historical or traditional use (may or may not be supported by scientific studies): In ancient times, the red-brown resin of myrrh was utilized in the preservation of mummies. It was also used as a remedy for numerous infections, including leprosy and syphilis. Myrrh was also recommended for relief from bad breath and for dental conditions. In traditional Chinese medicine, it has been used for bleeding disorders and wounds. Active constituents: The three main constituents of myrrh are the resin, the gum, and the volatile oil. All are important in myrrh’s activity as an herbal medicine. The resin has been shown to kill various microbes and to stimulate macrophages (a type of white blood cell).2 Myrrh also has astringent properties and has a soothing effect on inflamed tissues in the mouth and throat. Studies continue on the potential anticancer and pain-relieving actions of myrrh resin
   
   
2. 6/13/02 Myrrh as Anti Cancer Therapy "Myrrh has a long history of healing, with many references throughout the ages to its health-giving properties, with virtually no toxicity," says study co-author Mohamed M. Rafi, an assistant professor in the department of food science at Rutgers. Hailed for its anti-inflammatory and disinfectant properties, myrrh has historically been used for ailments as diverse as stomach pain, indigestion, poor circulation, wound healing, certain skin diseases and irregular menstrual cycles.
   
   
3. 6/13/02 A safe, effective, herbal antischistosomal therapy derived from myrrh. Am J Trop Med Hyg 2001 Dec;65(6):700-4 PMID: 11791960 Schistosomiasis is a widespread helminthic disease. Treatment of schistosomiasis is based on chemotherapy with praziquantel, which is the drug of choice. Since resistance to praziquantel has been demonstrated, alternative drugs must be considered. Myrrh is an oleo-gum resin from the stem of the plant Commiphora molmol. This study was carried out on 204 patients with schistosomiasis. The drug was given at a dose of 10 mg/kg of body weight/day for three days, and induced a cure rate of 91.7%. Re-treatment of cases who did not respond with a dose of 10 mg/kg of body weight/day for six days gave a cure rate of 76.5%, increasing the overall cure rate to 98.09%. The drug was well tolerated, and side effects were mild and transient. Twenty cases provided biopsy specimens six months after treatment and none of them showed living ova.
   
   
4. 6/13/02 Preliminary study of therapeutic efficacy of a new fasciolicidal drug derived from Commiphora molmol (myrrh). Am J Trop Med Hyg 2001 Aug;65(2):96-9 PMID: 11508399 The therapy proved to be effective, with pronounced improvement of the general condition and amelioration of all symptoms and signs. A dramatic drop in the egg count was detected at the end of treatment. Eggs were no longer detectable in the feces 3 weeks after treatment and after a follow-up period of 3 months. High eosinophilic counts, elevated liver enzymes, and Fasciola antibody titers returned to nearly normal. No signs of toxicity or adverse effects were observed. We conclude that the formulation of myrrh is safe, well tolerated, and effective for treating fascioliasis.
   
   

Home